SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: Access Pharmaceutical (AXCS)

No earlier versions found for this Subject.


Return to Access Pharmaceutical (AXCS)
 
To lead the industry in advanced drug delivery by surpassing currently
available technology through the use of Endo-Biologic Polymer Systems
as bioresponsive carriers which target sites of disease activity and
can take advantage of the body's own mechanisms to significantly enhance
the clinical effectiveness of a broad spectrum of products.

Formerly (Jan '96) Chemex Pharmaceutical.

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News